Evidence map›Paper›PMID 32343962›Full record

ArticleChest2020

Machine Learning Algorithms to Differentiate Among Pulmonary Complications After Hematopoietic Cell Transplant.

Husham Sharifi, Yu Kuang Lai, Henry Guo, Mita Hoppenfeld, Zachary D Guenther, Laura Johnston, Theresa Brondstetter, Laveena Chhatwani, Mark R Nicolls, Joe L Hsu

Open access · bronzeAbstract read
In one paragraph

Article in Chest, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Noninfectious complications of hematopoietic cell transplantation.Hematology. American Society of Hematology. Education Program · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Husham SharifiDepartment of Medicine, the Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Yu Kuang LaiDepartment of Medicine, the Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Henry GuoDepartments of Radiology, Stanford University School of Medicine, Stanford, CA.
Mita HoppenfeldDepartments of Medicine, Stanford University School of Medicine, Stanford, CA.
Zachary D GuentherDepartments of Radiology, Stanford University School of Medicine, Stanford, CA.
Laura JohnstonDepartment of Medicine, Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA.
Theresa BrondstetterDepartment of Medicine, the Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Laveena ChhatwaniDepartment of Medicine, the Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Mark R NicollsDepartment of Medicine, the Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Joe L HsuDepartment of Medicine, the Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA. Electronic address: joehsu@stanford.edu.
Stanford University · US

Funding

TUMOR SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN BONE MARROW TRANSPLANTATIONP01CA049605 · NCI · STANFORD UNIVERSITY · PI David B. Miklos · 1989 to 2026
$73.3M
VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTSP01HL075462 · NHLBI · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G. · 2004 to 2020
$27.9M
Endothelial Injury, BMPR2 Dysfunction and Macrophage Activation Cause EndMT and PAHR01HL138473 · NHLBI · STANFORD UNIVERSITY · PI Mark Robert Nicolls, Marlene Rabinovitch · 2017 to 2026
$4.9M
Critical Role for Microvasculature in Airway TransplantationR01HL095686 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI NICOLLS, MARK ROBERT · 2010 to 2022
$4.7M
A critical role for macrophage ferroptosis in promoting fungal invasion in lung transplant recipientsR01HL157414 · NHLBI · STANFORD UNIVERSITY · PI HSU, JOE L · 2021 to 2025
$3.0M
A Critical Role for Leukotriene B4 in LymphedemaR01HL141105 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI NICOLLS, MARK ROBERT · 2019 to 2022
$2.3M
HIF-1 mediated vascular integrity limits Aspergillus invasion in airway rejectionK08HL122528 · NHLBI · STANFORD UNIVERSITY · PI HSU, JOE L · 2015 to 2019
$804k
NCI NIH HHS P01 CA049605NHLBI NIH HHS K08 HL122528NHLBI NIH HHS P01 HL014985NHLBI NIH HHS P01 HL075462NHLBI NIH HHS R01 HL095686NHLBI NIH HHS R01 HL141105NHLBI NIH HHS R01 HL157414
6 · The paper itself

Abstract

backgroundPulmonary complications, including infections, are highly prevalent in patients after hematopoietic cell transplantation with chronic graft-vs-host disease. These comorbid diseases can make the diagnosis of early lung graft-vs-host disease (bronchiolitis obliterans syndrome) challenging. A quantitative method to differentiate among these pulmonary diseases can address diagnostic challenges and facilitate earlier and more targeted therapy. STUDY DESIGN AND

methodsWe conducted a single-center study of 66 patients with CT chest scans analyzed with a quantitative imaging tool known as parametric response mapping. Parametric response mapping results were correlated with pulmonary function tests and clinical characteristics. Five parametric response mapping metrics were applied to K-means clustering and support vector machine models to distinguish among posttransplantation lung complications solely from quantitative output.

resultsCompared with parametric response mapping, spirometry showed a moderate correlation with radiographic air trapping, and total lung capacity and residual volume showed a strong correlation with radiographic lung volumes. K-means clustering analysis distinguished four unique clusters. Clusters 2 and 3 represented obstructive physiology (encompassing 81% of patients with bronchiolitis obliterans syndrome) in increasing severity (percentage air trapping 15.6% and 43.0%, respectively). Cluster 1 was dominated by normal lung, and cluster 4 was characterized by patients with parenchymal opacities. A support vector machine algorithm differentiated bronchiolitis obliterans syndrome with a specificity of 88%, sensitivity of 83%, accuracy of 86%, and an area under the receiver operating characteristic curve of 0.85.

interpretationOur machine learning models offer a quantitative approach for the identification of bronchiolitis obliterans syndrome vs other lung diseases, including late pulmonary complications after hematopoietic cell transplantation.

Indexed as

Bronchiolitis ObliteransHematopoietic Stem Cell TransplantationAlgorithmsHumansLungMachine Learningbone marrowbronchiolitis obliteransgraft vs hostmedical informaticsorganizing pneumoniaradiology—thoracic

Identifiers

PMID32343962
PMCPMC8097633
OpenAlexW3017465709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.